Inmed Pharmaceuticals Inc. · NASDAQ:INM
Vivo Opportunity Fund Holdings, L.P. reported a 21.70% stake in Inmed Pharmaceuticals Inc. (Schedule 13D)
Event May 19, 2026 · Filed Jun 10, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 21.70% stake in Inmed Pharmaceuticals Inc., 718,444 shares, with active intent on May 19, 2026. Filed Jun 10, 2026 (Schedule 13D).
- Stake
- 21.70%
- Shares
- 718,444
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 21.70% | 718,444 |
| Vivo Opportunity, LLC | 21.70% | 718,444 |
| Vivo Opportunity Cayman Fund, L.P. | 2.20% | 72,535 |
| Vivo Opportunity Cayman, LLC | 2.20% | 72,535 |
Source
Related
- Inmed Pharmaceuticals Inc.
- Vivo Opportunity, LLC
- Inmed Pharmaceuticals Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 20, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 15, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 8, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Oct 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 5, 2026